Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

An Introduction
To Arcinova


"We are very impressed with the high quality work Arcinova provided in all aspects. We strongly recommend Arcinova. It has been a great pleasure to work with the Arcinova team" - US Biotech, commenting on CMC [Microbiology]

Integrated Services,
Under One Roof

Whether you require drug substance process route selection, bioanalysis, synthesis, scale up of APIs/HPAPIs or final drug product manufacture, we have the expertise on-site to deliver quality solutions.

What Customers Said

Latest News

New case study released: Bringing the Manufacturing Process to Life Adapting from Terminal Sterilisation to Aseptic Manufacture

Read More

Accelerated Formulation Case Study Released

Read More

Arcinova to host 2020 EBF YSS

Read More

Steve Bagshaw featured in BBC Inside Science podcast "Coronavirus: The types of vaccine; How the UK is scaling up vaccine production"

Read More